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Introduction
Vitamin D deficiency rickets (VDDR) remains to be a
common disorder in developing countries. In a recent 
study, it was shown that after the nationwide vitamin D 
supplementation campaign in 2005, the prevalence of 
VDDR declined from 6.09% to 0.099% in children aged
between 0-3 years in Turkey (1). There are some studies
reporting the resurgence of this disorder in developed 
countries (2,3).
Pseudohypoparathyroidism (PHP) is an inherited 
disorder characterized by an end-organ resistance to
parathormone (PTH). Children with PHP present with
hypocalcemia and normal or elevated serum phosphorus (P)
concentrations despite elevated serum PTH levels. The 
disorder is subdivided into several distinct entities. PHP type
1 is differentiated from PHP type 2 by reduced urinary cAMP
excretion in response to administration of PTH. 
Pediatricians in developed countries have limited 
experience in treating children with VDDR (4). PHP 
and VDDR can be mistaken for one another because of 
similarity in their presentation and biochemical features. 
Here we report a 23-month-old male patient presenting
with recurrent febrile convulsions and diagnosed 
as antiepileptic drug (AED)-induced VDDR. The initial levels
of serum Ca, P, PTH and tubular phosphate reabsorption
were suggestive of PHP.
Case Report 
A 23-month-old male was brought to our clinic for 
evaluation of fever. He was born at term with a birth weight
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convulsion for the first time at age 8 months and,
antiepileptic phenobarbital treatment was started. The
patient had had febrile convulsions on 7 different occasions
since then. He was breastfed only until 6 months of age
and received complementary feedings thereafter. The
infant was given 400 U/day vitamin D supplementation only
in the first two months of life. His neurodevelopment was
appropriate for age. The patient had a history of frequent
infections. He had been hospitalized due to pyelonephritis
at the age of 16 months. 
On physical examination, his height was 84 cm 
(25th-50th percentile), weight 12.5 kg (50th percentile), head
circumference 48 cm (50th percentile). Mild enlargement of
the wrists was noted bilaterally. Interpopliteal distance was
5.5 cm (N:<4.5 cm). Rachitic rosary, craniotabes, caput
quadratum, and leg deformities (O-/X-bine) were not 
present. He had also no signs suggestive of Albright’s
hereditary osteodystrophy (AHO), such as short hands,
round face, central obesity or dental hypoplasia.
Initial laboratory investigations showed the following
levels:  glucose 104 mg/dL, Na 134 mmol/L, K 4.5 mmol/L,
BUN 8 mg/dL, creatinine 0.4 mg/dL, Ca 6.4 mg/dL (N: 8.8-
10.8), P 6.7 mg/dL (N: 3.8-6.5), Mg 0.9 mmol/L (N:0.6-0.95),
alkaline phosphatase (ALP): 436 IU/L (N:145-420), total 
protein 6.5 g/dL (N:6.1-7.9), albumin 4.4 g/dL (N:3.5-5), PTH
390.7 pg/mL (N:11.1-79). Left hand and wrist X-ray showed
no findings of rickets. Upon these results, PHP or VDDR
was suspected. Urinary Ca/creatinine ratio was 0.26
(N:<0.6). Tubular reabsorption of phosphate was 0.99
(N:>0.90). Aminoaciduria was absent. EEG was normal. Ca
replacement was started in a dose of 50 mg/kg/day. 
The level of serum 25-hydroxyvitamin D [(25(OH)D] was
low-4.5 ug/L. A diagnosis of vitamin D deficiency was made
and, oral 300 000 U vitamin D was started. In 
addition, oral Ca was given for 15 days. Three weeks later,
serum Ca level was 9.2 mg/dL, P 6 mg/dL, ALP 354 U/L.
The level of PTH had decreased to 37 pg/mL, thus, the
diagnosis of PHP was excluded. Vitamin D in a dose of 
400 IU/day was prescribed. Regular follow-up, including
measurement of serum 25(OH)D levels, was recommended.
Discussion 
VDDR is a disorder biochemically characterized by 
elevated serum ALP activity, normal or decreased serum 
Ca and inorganic phosphate concentrations, secondary
hyperparathyroidism and decreased serum 25(OH)D levels.
Fraser et al (5) described three stages of VDDR on the basis
of clinical and laboratory data. Stage 1 is characterized by
hypocalcemia, normal P, normal urinary amino acid and
phosphate excretion with minimal or no findings of rickets
on radiographs. Stage 2 is associated with normal serum Ca
and low P concentrations in the presence of phosphaturia
and aminoaciduria and mild to moderate rickets findings on
X-rays. Stage 3 is similar to stage 2 but associated with
hypocalcemia and advanced rickets. In this original study,
which is based on the classical teaching of rickets staging,
hypocalcemia was attributed to lack of PTH secretion in the
first stage of VDDR. The earlier studies also showed normal
PTH levels in this stage (6). Later on, it was shown that PTH
levels were actually increased in stage 1 of VDDR at a time
when the phosphaturia or aminoaciduria were still absent. It
was also shown that the regulation and action of PTH were
disturbed in vitamin D deficiency, and restored after 
vitamin D treatment (7). Srivastava (4) was the first to draw
attention to the possibility that the elevated PTH levels
associated with hypocalcemia and normal P indicate an 
element of end-organ resistance to PTH, mimicking PHP. 
PHP is a genetic disorder associated with increased
secretion of PTH and target-tissue unresponsiveness to 
the biological actions of PTH. In PHP patients, biochemical
findings (hypocalcemia and hyperphosphatemia) are 
consistent with hypoparathyroidism. PHP type 1a is 
characterized by hormone resistance in addition to a 
peculiar constellation of developmental and somatic
defects that are collectively termed as AHO. The AHO 
phenotype consists of short stature, round face, obesity,
brachydactyly, subcutaneous ossifications, and rarely dental
defects and sensorineural abnormalities. Our patient had
none of these findings. Similar to patients with PHP type 2,
patients with PHP type 1b present with only PTH resistance
in the absence of features of AHO. The mutations 
of GNAS1, a gene encoding the alpha- subunit of the G
stimulatory protein, are responsible for the two main 
subtypes of PHP, namely types 1a and 1b. Type 1c, 
the rarest subtype, is characterized by AHO as well as
resistance to PTH and other hormones associated with 
normal Gs α activity. In our patient, the clinical findings and
initial laboratory results suggested PHP type 2 or PHP type 1b. 
There are several studies reporting on the difficulty in
differentiating stage 1 VDDR from PHP (4,8,9). Serum PTH
levels cannot be relied on to differentiate between these
two disorders. A detailed history should be taken, including
vitamin D intake, sun exposure and use of drugs that 
interfere with vitamin D metabolism. In our patient, vitamin
D support was inadequate and phenobarbital treatment
probably aggravated the deficiency. Evidence of rickets on
physical and radiological examination is also important in
the differential diagnosis, although clinical signs may be
minimal or absent in stage 1 VDDR. On the other hand, PHP
may present with bony deformities resembling rickets (10).
The hallmark of VDDR is vitamin D depletion (low serum 25
(OH)D), since serum Ca, P and 1,25 (OH)2D levels can be
variable  (7). Nevertheless, if the differential diagnosis 
cannot be made properly in marginal cases, showing the
normalization of biochemical and physical abnormalities
after vitamin D treatment may help in clarifying the diagnosis
(4). Although the clinical and radiological findings were
vague in our patient, the 25 (OH)D level was found low 
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normalization of serum Ca, P, ALP and PTH in three weeks.
Febrile seizures, a common and usually benign 
complaint in infancy and early childhood, are not known to
be associated with rickets. Hoecker et al (11) reported 
that recurrent febrile convulsions might be an unusual 
presentation of nutritional rickets. Since vitamin D is 
reported to have an important role in immune defense
mechanisms  (12), it may be speculated that the febrile 
convulsions triggered by fever during frequent infections in
this patient could be attributable to vitamin D deficiency.
There are several studies reporting that decreased
serum 25(OH)D and altered bone metabolism were 
associated with AED treatment in children (13). Many AEDs
are known to be inducers of hepatic cytochrome P450
metabolism, resulting in increased hepatic metabolism of
vitamin D. Some authors recommend monitoring of the
vitamin D status in children taking AEDs, especially those
receiving polypharmacotherapy (14). In our patient, we
thought that in addition to inadequate vitamin D intake,
usage of AED may have led to the worsening of the vitamin
D deficiency.
In conclusion, reporting this case we desire to emphasize
that VDDR can be mistaken for PHP in some cases. 
The demonstration of normalization of phosphocalcic
parameters (i.e. serum Ca, P, ALP and PTH) after vitamin D
treatment may be useful in the differentiation of these two
disorders. Vitamin D deficiency should be kept in mind in
the differential diagnosis of hypocalcemia in children, 
especially those being treated with AEDs. 
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